ID ACSL6_HUMAN Reviewed; 697 AA. AC Q9UKU0; J3KPG3; O94924; O95829; Q108M9; Q108N0; Q4G191; Q86TN7; DT 27-APR-2001, integrated into UniProtKB/Swiss-Prot. DT 06-MAR-2007, sequence version 4. DT 27-MAR-2024, entry version 198. DE RecName: Full=Long-chain-fatty-acid--CoA ligase 6 {ECO:0000305}; DE EC=6.2.1.3 {ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233}; DE AltName: Full=Arachidonate--CoA ligase {ECO:0000305}; DE EC=6.2.1.15 {ECO:0000250|UniProtKB:P33124}; DE AltName: Full=Long-chain acyl-CoA synthetase 6; DE Short=LACS 6; GN Name=ACSL6 {ECO:0000312|HGNC:HGNC:16496}; GN Synonyms=ACS2, FACL6, KIAA0837, LACS5; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND TISSUE SPECIFICITY. RX PubMed=10548543; DOI=10.1042/bj3440135; RA Malhotra K.T., Malhotra K., Lubin B.H., Kuypers F.A.; RT "Identification and molecular characterization of acyl-CoA synthetase in RT human red cells and erythroid precursor."; RL Biochem. J. 344:135-143(1999). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND CHROMOSOMAL TRANSLOCATION WITH RP ETV6. RC TISSUE=Bone marrow; RX PubMed=10502316; RX DOI=10.1002/(sici)1098-2264(199911)26:3<192::aid-gcc2>3.0.co;2-e; RA Yagasaki F., Jinnai I., Yoshida S., Yokoyama Y., Matsuda A., Kusumoto S., RA Kobayashi H., Terasaki H., Ohyashiki K., Asou N., Murohashi I., Bessho M., RA Hirashima K.; RT "Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute RT myelogenous leukemia with t(5;12)(q31;p13)."; RL Genes Chromosomes Cancer 26:192-202(1999). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), NUCLEOTIDE SEQUENCE [MRNA] OF RP 253-374 (ISOFORM 5), AND ALTERNATIVE SPLICING (ISOFORM 8). RX PubMed=16834775; DOI=10.1186/1471-2199-7-21; RA Soupene E., Kuypers F.A.; RT "Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are RT produced by switch of the fatty acid gate domains."; RL BMC Mol. Biol. 7:21-21(2006). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Brain; RX PubMed=10048485; DOI=10.1093/dnares/5.6.355; RA Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N., RA Tanaka A., Kotani H., Nomura N., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XII. The RT complete sequences of 100 new cDNA clones from brain which code for large RT proteins in vitro."; RL DNA Res. 5:355-364(1998). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). RC TISSUE=Brain; RA Li W.B., Gruber C., Jessee J., Polayes D.; RT "Full-length cDNA libraries and normalization."; RL Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING RP (ISOFORM 8). RX PubMed=15372022; DOI=10.1038/nature02919; RA Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., RA Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., RA She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S., RA Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M., RA Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M., RA Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T., RA Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., RA Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R., RA Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L., RA Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N., RA Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., RA Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., RA Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.; RT "The DNA sequence and comparative analysis of human chromosome 5."; RL Nature 431:268-274(2004). RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 7 AND 9). RC TISSUE=Testis; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP CATALYTIC ACTIVITY, AND FUNCTION. RX PubMed=22633490; DOI=10.1016/j.molcel.2012.04.033; RA Nakahara K., Ohkuni A., Kitamura T., Abe K., Naganuma T., Ohno Y., RA Zoeller R.A., Kihara A.; RT "The Sjogren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of RT the sphingosine 1-phosphate degradation pathway."; RL Mol. Cell 46:461-471(2012). RN [9] RP CATALYTIC ACTIVITY, FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=24269233; DOI=10.1016/j.bbrc.2013.11.036; RA Ohkuni A., Ohno Y., Kihara A.; RT "Identification of acyl-CoA synthetases involved in the mammalian RT sphingosine 1-phosphate metabolic pathway."; RL Biochem. Biophys. Res. Commun. 442:195-201(2013). CC -!- FUNCTION: Catalyzes the conversion of long-chain fatty acids to their CC active form acyl-CoA for both synthesis of cellular lipids, and CC degradation via beta-oxidation (PubMed:22633490, PubMed:24269233). CC Plays an important role in fatty acid metabolism in brain and the acyl- CC CoAs produced may be utilized exclusively for the synthesis of the CC brain lipid. {ECO:0000269|PubMed:22633490, CC ECO:0000269|PubMed:24269233}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a long-chain fatty acid + ATP + CoA = a long-chain fatty acyl- CC CoA + AMP + diphosphate; Xref=Rhea:RHEA:15421, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57560, CC ChEBI:CHEBI:83139, ChEBI:CHEBI:456215; EC=6.2.1.3; CC Evidence={ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15422; CC Evidence={ECO:0000305|PubMed:22633490, ECO:0000305|PubMed:24269233}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA = CC (5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:19713, ChEBI:CHEBI:30616, ChEBI:CHEBI:32395, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, CC ChEBI:CHEBI:456215; EC=6.2.1.15; CC Evidence={ECO:0000250|UniProtKB:P33124}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19714; CC Evidence={ECO:0000250|UniProtKB:P33124}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + hexadecanoate = AMP + diphosphate + hexadecanoyl- CC CoA; Xref=Rhea:RHEA:30751, ChEBI:CHEBI:7896, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, CC ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:24269233}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30752; CC Evidence={ECO:0000305|PubMed:24269233}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(E)-hexadec-2-enoate + ATP + CoA = (2E)-hexadecenoyl-CoA + AMP CC + diphosphate; Xref=Rhea:RHEA:36139, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:61526, CC ChEBI:CHEBI:72745, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36140; CC Evidence={ECO:0000305|PubMed:22633490, ECO:0000305|PubMed:24269233}; CC -!- CATALYTIC ACTIVITY: CC Reaction=15-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + ATP + CoA = 15- CC hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:52116, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:78832, ChEBI:CHEBI:136409, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:P33124}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52117; CC Evidence={ECO:0000250|UniProtKB:P33124}; CC -!- CATALYTIC ACTIVITY: CC Reaction=12-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + ATP + CoA = 12- CC hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:52112, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:90718, ChEBI:CHEBI:136408, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:P33124}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52113; CC Evidence={ECO:0000250|UniProtKB:P33124}; CC -!- CATALYTIC ACTIVITY: CC Reaction=5-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA = 5- CC hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:52108, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:65341, ChEBI:CHEBI:136407, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:P33124}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52109; CC Evidence={ECO:0000250|UniProtKB:P33124}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC -!- INTERACTION: CC Q9UKU0-7; Q9NV79: PCMTD2; NbExp=3; IntAct=EBI-12883224, EBI-6309018; CC Q9UKU0-7; Q8N720: ZNF655; NbExp=3; IntAct=EBI-12883224, EBI-625509; CC -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250}; CC Single-pass type III membrane protein {ECO:0000250}. Peroxisome CC membrane {ECO:0000250}; Single-pass type III membrane protein CC {ECO:0000250}. Microsome membrane {ECO:0000250}; Single-pass type III CC membrane protein {ECO:0000250}. Endoplasmic reticulum membrane CC {ECO:0000269|PubMed:24269233}; Single-pass type III membrane protein CC {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=9; CC Name=4; CC IsoId=Q9UKU0-4; Sequence=Displayed; CC Name=1; Synonyms=Long, v2; CC IsoId=Q9UKU0-1; Sequence=VSP_037819; CC Name=2; Synonyms=Short; CC IsoId=Q9UKU0-2; Sequence=VSP_021024, VSP_000241; CC Name=3; CC IsoId=Q9UKU0-3; Sequence=VSP_021024; CC Name=5; Synonyms=v4; CC IsoId=Q9UKU0-5; Sequence=VSP_037823; CC Name=6; Synonyms=v5; CC IsoId=Q9UKU0-6; Sequence=VSP_037821; CC Name=7; Synonyms=v3; CC IsoId=Q9UKU0-7; Sequence=VSP_037820, VSP_037822; CC Name=8; Synonyms=v1; CC IsoId=Q9UKU0-8; Sequence=VSP_037819, VSP_021024; CC Name=9; CC IsoId=Q9UKU0-9; Sequence=VSP_046954; CC -!- TISSUE SPECIFICITY: Expressed predominantly in erythrocyte precursors, CC in particular in reticulocytes, fetal blood cells derived from fetal CC liver, hemopoietic stem cells from cord blood, bone marrow and brain. CC {ECO:0000269|PubMed:10548543}. CC -!- DEVELOPMENTAL STAGE: Expression is low at earlier stages of erythroid CC development but is very high in reticulocytes. CC -!- DISEASE: Note=A chromosomal aberration involving ACSL6 may be a cause CC of myelodysplastic syndrome with basophilia. Translocation CC t(5;12)(q31;p13) with ETV6. {ECO:0000269|PubMed:10502316}. CC -!- DISEASE: Note=A chromosomal aberration involving ACSL6 may be a cause CC of acute myelogenous leukemia with eosinophilia. Translocation CC t(5;12)(q31;p13) with ETV6. {ECO:0000269|PubMed:10502316}. CC -!- DISEASE: Note=A chromosomal aberration involving ACSL6 may be a cause CC of acute eosinophilic leukemia (AEL). Translocation t(5;12)(q31;p13) CC with ETV6. {ECO:0000269|PubMed:10502316}. CC -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH26161.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305}; CC Sequence=BAA74860.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF129166; AAD47199.1; -; mRNA. DR EMBL; AF099740; AAD17853.1; -; mRNA. DR EMBL; DQ083030; AAZ30713.1; -; mRNA. DR EMBL; DQ083031; AAZ30714.1; -; mRNA. DR EMBL; AB020644; BAA74860.1; ALT_INIT; mRNA. DR EMBL; CR606980; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; AC025772; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC026398; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC034228; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC026161; AAH26161.1; ALT_SEQ; mRNA. DR EMBL; BC047453; AAH47453.1; -; mRNA. DR CCDS; CCDS34228.1; -. [Q9UKU0-8] DR CCDS; CCDS34229.1; -. [Q9UKU0-1] DR CCDS; CCDS56381.1; -. [Q9UKU0-3] DR CCDS; CCDS56382.1; -. [Q9UKU0-7] DR CCDS; CCDS56383.1; -. [Q9UKU0-9] DR RefSeq; NP_001009185.1; NM_001009185.2. [Q9UKU0-1] DR RefSeq; NP_001192176.1; NM_001205247.1. DR RefSeq; NP_001192177.1; NM_001205248.1. [Q9UKU0-3] DR RefSeq; NP_001192179.1; NM_001205250.1. [Q9UKU0-9] DR RefSeq; NP_001192180.1; NM_001205251.1. [Q9UKU0-7] DR RefSeq; NP_056071.2; NM_015256.3. [Q9UKU0-8] DR AlphaFoldDB; Q9UKU0; -. DR SMR; Q9UKU0; -. DR BioGRID; 116897; 10. DR IntAct; Q9UKU0; 5. DR STRING; 9606.ENSP00000498260; -. DR BindingDB; Q9UKU0; -. DR ChEMBL; CHEMBL4680042; -. DR SwissLipids; SLP:000000203; -. DR iPTMnet; Q9UKU0; -. DR PhosphoSitePlus; Q9UKU0; -. DR BioMuta; ACSL6; -. DR DMDM; 146322303; -. DR EPD; Q9UKU0; -. DR jPOST; Q9UKU0; -. DR MassIVE; Q9UKU0; -. DR MaxQB; Q9UKU0; -. DR PaxDb; 9606-ENSP00000368566; -. DR PeptideAtlas; Q9UKU0; -. DR ProteomicsDB; 84870; -. [Q9UKU0-4] DR ProteomicsDB; 84871; -. [Q9UKU0-1] DR ProteomicsDB; 84872; -. [Q9UKU0-2] DR ProteomicsDB; 84873; -. [Q9UKU0-3] DR ProteomicsDB; 84874; -. [Q9UKU0-5] DR ProteomicsDB; 84875; -. [Q9UKU0-6] DR ProteomicsDB; 84876; -. [Q9UKU0-7] DR ProteomicsDB; 84877; -. [Q9UKU0-8] DR Antibodypedia; 25915; 228 antibodies from 29 providers. DR DNASU; 23305; -. DR Ensembl; ENST00000357096.5; ENSP00000349608.1; ENSG00000164398.15. [Q9UKU0-7] DR Ensembl; ENST00000379240.5; ENSP00000368542.1; ENSG00000164398.15. [Q9UKU0-4] DR Ensembl; ENST00000379244.5; ENSP00000368546.1; ENSG00000164398.15. [Q9UKU0-3] DR Ensembl; ENST00000379246.5; ENSP00000368548.1; ENSG00000164398.15. [Q9UKU0-9] DR Ensembl; ENST00000379255.5; ENSP00000368557.1; ENSG00000164398.15. [Q9UKU0-7] DR Ensembl; ENST00000543479.5; ENSP00000442124.2; ENSG00000164398.15. [Q9UKU0-6] DR Ensembl; ENST00000651356.1; ENSP00000498260.1; ENSG00000164398.15. [Q9UKU0-8] DR Ensembl; ENST00000651883.2; ENSP00000499063.2; ENSG00000164398.15. [Q9UKU0-1] DR GeneID; 23305; -. DR KEGG; hsa:23305; -. DR MANE-Select; ENST00000651883.2; ENSP00000499063.2; NM_001009185.3; NP_001009185.1. [Q9UKU0-1] DR UCSC; uc003kvv.3; human. [Q9UKU0-4] DR AGR; HGNC:16496; -. DR CTD; 23305; -. DR DisGeNET; 23305; -. DR GeneCards; ACSL6; -. DR HGNC; HGNC:16496; ACSL6. DR HPA; ENSG00000164398; Tissue enhanced (bone marrow, brain, retina). DR MIM; 604443; gene. DR neXtProt; NX_Q9UKU0; -. DR OpenTargets; ENSG00000164398; -. DR PharmGKB; PA27970; -. DR VEuPathDB; HostDB:ENSG00000164398; -. DR eggNOG; KOG1256; Eukaryota. DR GeneTree; ENSGT00940000162308; -. DR HOGENOM; CLU_000022_45_4_1; -. DR InParanoid; Q9UKU0; -. DR OMA; PRIWTKF; -. DR OrthoDB; 443463at2759; -. DR PhylomeDB; Q9UKU0; -. DR TreeFam; TF313877; -. DR BioCyc; MetaCyc:HS15193-MONOMER; -. DR BRENDA; 6.2.1.3; 2681. DR PathwayCommons; Q9UKU0; -. DR Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs. DR SignaLink; Q9UKU0; -. DR BioGRID-ORCS; 23305; 6 hits in 1149 CRISPR screens. DR ChiTaRS; ACSL6; human. DR GeneWiki; ACSL6; -. DR GenomeRNAi; 23305; -. DR Pharos; Q9UKU0; Tbio. DR PRO; PR:Q9UKU0; -. DR Proteomes; UP000005640; Chromosome 5. DR RNAct; Q9UKU0; Protein. DR Bgee; ENSG00000164398; Expressed in lateral nuclear group of thalamus and 140 other cell types or tissues. DR ExpressionAtlas; Q9UKU0; baseline and differential. DR GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB. DR GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome. DR GO; GO:0016020; C:membrane; IDA:UniProtKB. DR GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005886; C:plasma membrane; NAS:UniProtKB. DR GO; GO:0047676; F:arachidonate-CoA ligase activity; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0019899; F:enzyme binding; IPI:UniProtKB. DR GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB. DR GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB. DR GO; GO:0006637; P:acyl-CoA metabolic process; NAS:UniProtKB. DR GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB. DR GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; IBA:GO_Central. DR GO; GO:0007405; P:neuroblast proliferation; IEA:Ensembl. DR GO; GO:0000038; P:very long-chain fatty acid metabolic process; IBA:GO_Central. DR CDD; cd05927; LC-FACS_euk; 1. DR Gene3D; 3.40.50.12780; N-terminal domain of ligase-like; 1. DR InterPro; IPR020845; AMP-binding_CS. DR InterPro; IPR000873; AMP-dep_Synth/Lig_com. DR InterPro; IPR042099; ANL_N_sf. DR InterPro; IPR045311; LC-FACS_euk. DR PANTHER; PTHR43272; LONG-CHAIN-FATTY-ACID--COA LIGASE; 1. DR PANTHER; PTHR43272:SF54; LONG-CHAIN-FATTY-ACID--COA LIGASE 6; 1. DR Pfam; PF00501; AMP-binding; 1. DR SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 1. DR PROSITE; PS00455; AMP_BINDING; 1. DR Genevisible; Q9UKU0; HS. PE 1: Evidence at protein level; KW Alternative splicing; ATP-binding; Chromosomal rearrangement; KW Endoplasmic reticulum; Fatty acid metabolism; Ligase; Lipid metabolism; KW Magnesium; Membrane; Microsome; Mitochondrion; KW Mitochondrion outer membrane; Nucleotide-binding; Peroxisome; KW Reference proteome; Transmembrane; Transmembrane helix. FT CHAIN 1..697 FT /note="Long-chain-fatty-acid--CoA ligase 6" FT /id="PRO_0000193115" FT TRANSMEM 25..45 FT /note="Helical; Signal-anchor for type III membrane FT protein" FT /evidence="ECO:0000255" FT TOPO_DOM 46..697 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT VAR_SEQ 1 FT /note="M -> MLTFFLVSGGSLWLFVEFVLSLLEKM (in isoform 1 and FT isoform 8)" FT /evidence="ECO:0000303|PubMed:10048485" FT /id="VSP_037819" FT VAR_SEQ 1 FT /note="M -> MPEFVLSLLEKM (in isoform 9)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_046954" FT VAR_SEQ 31..65 FT /note="Missing (in isoform 7)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_037820" FT VAR_SEQ 192 FT /note="T -> TGLSCQEGASATASTQ (in isoform 6)" FT /evidence="ECO:0000303|PubMed:16834775" FT /id="VSP_037821" FT VAR_SEQ 306..345 FT /note="Missing (in isoform 7)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_037822" FT VAR_SEQ 306..330 FT /note="KVIFPRQDDVLISFLPLAHMFERVI -> SQWAPTCADVHISYLPLAHMFER FT MV (in isoform 3, isoform 2 and isoform 8)" FT /evidence="ECO:0000303|PubMed:10502316, FT ECO:0000303|PubMed:10548543" FT /id="VSP_021024" FT VAR_SEQ 306..312 FT /note="Missing (in isoform 5)" FT /evidence="ECO:0000303|PubMed:16834775" FT /id="VSP_037823" FT VAR_SEQ 653..697 FT /note="VKAIHIHSDMFSVQNGLLTPTLKAKRPELREYFKKQIEELYSISM -> DLP FT QCLIQIKVFSKY (in isoform 2)" FT /evidence="ECO:0000303|PubMed:10502316" FT /id="VSP_000241" FT CONFLICT 19 FT /note="G -> E (in Ref. 1; AAD47199)" FT /evidence="ECO:0000305" FT CONFLICT 46 FT /note="H -> Q (in Ref. 1; AAD47199)" FT /evidence="ECO:0000305" FT CONFLICT 257 FT /note="E -> A (in Ref. 7; AAH47453)" FT /evidence="ECO:0000305" FT CONFLICT 260 FT /note="Q -> L (in Ref. 7; AAH26161)" FT /evidence="ECO:0000305" FT CONFLICT 356 FT /note="K -> R (in Ref. 3; AAZ30714)" FT /evidence="ECO:0000305" FT CONFLICT 696 FT /note="S -> P (in Ref. 1; AAD47199 and 3; AAZ30714)" FT /evidence="ECO:0000305" SQ SEQUENCE 697 AA; 77752 MW; AC566177B47D0975 CRC64; MQTQEILRIL RLPELGDLGQ FFRSLSATTL VSMGALAAIL AYWFTHRPKA LQPPCNLLMQ SEEVEDSGGA RRSVIGSGPQ LLTHYYDDAR TMYQVFRRGL SISGNGPCLG FRKPKQPYQW LSYQEVADRA EFLGSGLLQH NCKACTDQFI GVFAQNRPEW IIVELACYTY SMVVVPLYDT LGPGAIRYII NTADISTVIV DKPQKAVLLL EHVERKETPG LKLIILMDPF EEALKERGQK CGVVIKSMQA VEDCGQENHQ APVPPQPDDL SIVCFTSGTT GNPKGAMLTH GNVVADFSGF LKVTEKVIFP RQDDVLISFL PLAHMFERVI QSVVYCHGGR VGFFQGDIRL LSDDMKALCP TIFPVVPRLL NRMYDKIFSQ ANTPLKRWLL EFAAKRKQAE VRSGIIRNDS IWDELFFNKI QASLGGCVRM IVTGAAPASP TVLGFLRAAL GCQVYEGYGQ TECTAGCTFT TPGDWTSGHV GAPLPCNHIK LVDVEELNYW ACKGEGEICV RGPNVFKGYL KDPDRTKEAL DSDGWLHTGD IGKWLPAGTL KIIDRKKHIF KLAQGEYVAP EKIENIYIRS QPVAQIYVHG DSLKAFLVGI VVPDPEVMPS WAQKRGIEGT YADLCTNKDL KKAILEDMVR LGKESGLHSF EQVKAIHIHS DMFSVQNGLL TPTLKAKRPE LREYFKKQIE ELYSISM //